We read with great interest the recent paper by Hawk et al. (1), who reported that male pattern baldness was significantly associated with increased risk for prostate cancer. Given that the study relied upon a prospective design, a large sample, and data that were appropriately analyzed, the report makes a substantive contribution to the literature related to potential risk factors for prostati...

BACKGROUND Male baldness is very common. Its effect on individuals is extremely variable, and in some people it will have a significant adverse effect on their quality of life. OBJECTIVE The objectives of this article are to help general practitioners (GPs) be aware of potential health problems related to male baldness, to have an approach to assessing hair loss and to be aware of treatment o...

We performed clinical trials to evaluate the therapeutic effects of Foltene in patients of the several types of hair fallings. Thirty patients with male pattern baldness, alopecia areata and seborrheic alopecia were included in this study. Foltene was applied every other day for 40 days, and followed by maintenance therapy of twice application a week. The duration of whole therapy was 6 months....

BACKGROUND Androgens play a role in the development of both androgenic alopecia, commonly known as male pattern baldness, and prostate cancer. We set out to study if early-onset androgenic alopecia was associated with an increased risk of prostate cancer later in life. PATIENTS AND METHODS A total of 669 subjects (388 with a history of prostate cancer and 281 without) were enrolled in this st...